News

【活動公告】2025 Taiwan Real-World Evidence Online Symposium 熱烈報名中!

Symposiums
Date: 2025-06-10
Hit: 87

【活動公告】2025 Taiwan Real-World Evidence Online Symposium 熱烈報名中!

 

OHDSI Taiwan Society 很榮幸擔任本次由 TOPharmNet 主辦之 2025 Taiwan Real-World Evidence Online Symposium 協辦單位,邀請您一同參與這場年度盛會!

 

這是一場為期三天半的線上研討會,集結來自台灣與北美的頂尖講者與學者,聚焦真實世界數據與實證研究的最新趨勢與應用實務。從政策策略、資料整合、方法創新到跨域合作,絕對不容錯過!

 

🔍 本次研討會四大核心主題:
真實世界數據於決策支持的應用與策略
資料品質與多元資料來源整合挑戰
目標試驗模擬(Target Trial Emulation
• AI與機器學習於醫療實證的創新應用

 

精彩活動同步登場,促進跨領域交流與合作:
Fireside ChatCareer PanelStudent Research SpotlightNetworking Event 等,涵蓋產學對話、職涯發展與研究分享,激盪新思維!

 

📌 活動資訊與報名連結: https://topharmnet.org/trwe2025/


🎯 早鳥優惠票至 6/28,名額有限,敬請把握!


💡 台灣藥師持續教育學分申請中!

 

[Event Announcement] 2025 Taiwan Real-World Evidence Online Symposium – Registration Now Open!

 

OHDSI Taiwan Society is proud to serve as a co-organizing partner of the 2025 Taiwan Real-World Evidence (RWE) Online Symposium, hosted by TOPharmNet. We warmly invite you to join this premier annual virtual event!

 

Spanning three and a half days, the symposium features prominent experts and scholars from Taiwan and North America, delivering leading-edge perspectives and practical experience in RWE. From decision-support strategies to cross-sector innovation, this is an event you don’t want to miss!

 

🔍 Key Themes:
• Applications and strategies of RWD in decision-making support
• Challenges in data quality and integration of diverse data sources
• Target trial emulation
• Innovative applications of AI and machine learning in healthcare evidence generation

 

Special sessions to foster cross-disciplinary exchange:
Fireside Chat, Career Panel, Student Research Spotlight, and Networking Event — engaging academia and industry for vibrant dialogue, career development, and research collaboration.

 

📌 For details and registration, visit: https://topharmnet.org/trwe2025/


🎯 Early-bird registration is open until June 28. Spots are limited — don’t miss out!


💡 Continuing education credits for Taiwan pharmacists are under application.